← Eichor
Condition: New Onset Type 2 Diabetes Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: New Onset Type 2 Diabetes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On
Phase 1/Phase 2 · 11 location(s) · City of Hope Medical Center · NCT07061574Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin T
Phase 4 · 1 location(s) · Zhejiang Provincial People's Hospital · NCT06888050Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Phase 3 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT06246799
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.